These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 18642328)
1. Increased PAK6 expression in prostate cancer and identification of PAK6 associated proteins. Kaur R; Yuan X; Lu ML; Balk SP Prostate; 2008 Oct; 68(14):1510-6. PubMed ID: 18642328 [TBL] [Abstract][Full Text] [Related]
2. Hormonal regulation of beta2-adrenergic receptor level in prostate cancer. Ramberg H; Eide T; Krobert KA; Levy FO; Dizeyi N; Bjartell AS; Abrahamsson PA; Taskén KA Prostate; 2008 Jul; 68(10):1133-42. PubMed ID: 18454446 [TBL] [Abstract][Full Text] [Related]
3. Reactive oxygen species mediate androgen receptor- and serum starvation-elicited downstream signaling of ADAM9 expression in human prostate cancer cells. Shigemura K; Sung SY; Kubo H; Arnold RS; Fujisawa M; Gotoh A; Zhau HE; Chung LW Prostate; 2007 May; 67(7):722-31. PubMed ID: 17342749 [TBL] [Abstract][Full Text] [Related]
4. [Cloning of human PAK6 cDNA, preparation of anti-PAK6 polyclonal antibody and PAK6 expression in prostate cancer]. Han YJ; An ZW; Yang JX; Li J; Luo RC; Zhang HQ Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jun; 27(6):827-30. PubMed ID: 17584649 [TBL] [Abstract][Full Text] [Related]
5. PC-1/PrLZ contributes to malignant progression in prostate cancer. Zhang H; Wang J; Pang B; Liang RX; Li S; Huang PT; Wang R; Chung LW; Zhau HE; Huang C; Zhou JG Cancer Res; 2007 Sep; 67(18):8906-13. PubMed ID: 17875733 [TBL] [Abstract][Full Text] [Related]
6. 1alpha,25-Dihydroxyvitamin D3 down-regulates expression of prostate specific membrane antigen in prostate cancer cells. Serda RE; Bisoffi M; Thompson TA; Ji M; Omdahl JL; Sillerud LO Prostate; 2008 May; 68(7):773-83. PubMed ID: 18247401 [TBL] [Abstract][Full Text] [Related]
7. Chronic azacitidine treatment results in differentiating effects, sensitizes against bicalutamide in androgen-independent prostate cancer cells. Gravina GL; Festuccia C; Millimaggi D; Dolo V; Tombolini V; de Vito M; Vicentini C; Bologna M Prostate; 2008 May; 68(7):793-801. PubMed ID: 18324645 [TBL] [Abstract][Full Text] [Related]
8. Alpha-methylacyl-CoA racemase as an androgen-independent growth modifier in prostate cancer. Zha S; Ferdinandusse S; Denis S; Wanders RJ; Ewing CM; Luo J; De Marzo AM; Isaacs WB Cancer Res; 2003 Nov; 63(21):7365-76. PubMed ID: 14612535 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens. Eisold M; Asim M; Eskelinen H; Linke T; Baniahmad A J Mol Endocrinol; 2009 May; 42(5):429-35. PubMed ID: 19223455 [TBL] [Abstract][Full Text] [Related]
10. Identification of mu-crystallin as an androgen-regulated gene in human prostate cancer. Malinowska K; Cavarretta IT; Susani M; Wrulich OA; Uberall F; Kenner L; Culig Z Prostate; 2009 Jul; 69(10):1109-18. PubMed ID: 19353593 [TBL] [Abstract][Full Text] [Related]
11. Regulation of matrix metalloproteinase 13 expression by androgen in prostate cancer. Pang ST; Flores-Morales A; Skoog L; Chuan YC; Nordstedt G; Pousette A Oncol Rep; 2004 Jun; 11(6):1187-92. PubMed ID: 15138554 [TBL] [Abstract][Full Text] [Related]
12. Androgen-dependent regulation of medium and long chain fatty acids uptake in prostate cancer. Pinthus JH; Lu JP; Bidaisee LA; Lin H; Bryskine I; Gupta RS; Singh G Prostate; 2007 Sep; 67(12):1330-8. PubMed ID: 17626249 [TBL] [Abstract][Full Text] [Related]
13. CaT1 expression correlates with tumor grade in prostate cancer. Peng JB; Zhuang L; Berger UV; Adam RM; Williams BJ; Brown EM; Hediger MA; Freeman MR Biochem Biophys Res Commun; 2001 Apr; 282(3):729-34. PubMed ID: 11401523 [TBL] [Abstract][Full Text] [Related]
14. Activity of androgen receptor antagonist bicalutamide in prostate cancer cells is independent of NCoR and SMRT corepressors. Hodgson MC; Astapova I; Hollenberg AN; Balk SP Cancer Res; 2007 Sep; 67(17):8388-95. PubMed ID: 17804755 [TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo effects of bicalutamide on the expression of TrkA and P75 neurotrophin receptors in prostate carcinoma. Festuccia C; Gravina GL; Muzi P; Pomante R; Ventura L; Ricevuto E; Vicentini C; Bologna M Prostate; 2007 Sep; 67(12):1255-64. PubMed ID: 17596848 [TBL] [Abstract][Full Text] [Related]
16. Expression of BNIP3 correlates with hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha and the androgen receptor in prostate cancer and is regulated directly by hypoxia but not androgens in cell lines. Shaida N; Launchbury R; Boddy JL; Jones C; Campo L; Turley H; Kanga S; Banham AH; Malone PR; Harris AL; Fox SB Prostate; 2008 Feb; 68(3):336-43. PubMed ID: 18163427 [TBL] [Abstract][Full Text] [Related]
17. Direct interaction between AR and PAK6 in androgen-stimulated PAK6 activation. Liu X; Busby J; John C; Wei J; Yuan X; Lu ML PLoS One; 2013; 8(10):e77367. PubMed ID: 24130878 [TBL] [Abstract][Full Text] [Related]
18. Androgen receptor controls EGFR and ERBB2 gene expression at different levels in prostate cancer cell lines. Pignon JC; Koopmansch B; Nolens G; Delacroix L; Waltregny D; Winkler R Cancer Res; 2009 Apr; 69(7):2941-9. PubMed ID: 19318561 [TBL] [Abstract][Full Text] [Related]
19. Androgen deprivation and androgen receptor competition by bicalutamide induce autophagy of hormone-resistant prostate cancer cells and confer resistance to apoptosis. Boutin B; Tajeddine N; Vandersmissen P; Zanou N; Van Schoor M; Mondin L; Courtoy PJ; Tombal B; Gailly P Prostate; 2013 Jul; 73(10):1090-102. PubMed ID: 23532738 [TBL] [Abstract][Full Text] [Related]
20. Androgens and estrogens stimulate ribosome biogenesis in prostate and breast cancer cells in receptor dependent manner. Ray S; Johnston R; Campbell DC; Nugent S; McDade SS; Waugh D; Panov KI Gene; 2013 Aug; 526(1):46-53. PubMed ID: 23608168 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]